The US Food and Drug Administration will no longer require premarket notifications for seven low-risk medical devices, and may stop requiring them for 83 more moderate-risk devices and an unclassified device.
The agency issued emergency guidance documents during the COVID-19 pandemic that temporarily suspended premarket notifications for a slew of class I low-risk products including clinical electronic thermometers, and personal protective equipment like surgical gloves and face masks
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?